Singapore biomed

The economic heavyweight, whose 16-year tenure at CDL’s board ends on Jul 31, played key roles in building Jurong Island and the biomedical sector

Added capabilities enable it to value-add and engage new customers, as well as pursue further collaborations with existing customers

The company says the deal paves the way for broader collaboration, exploring new avenues for strategic growth and development

SINGAPORE’S manufacturing output gained 1 per cent on year in November, extending October’s surprise 7.6 per cent growth after a year-long slump.

SINGAPORE’S factory output in October surpassed market expectations with a 7.4 per cent year-on-year rebound after a year-long slump, data from the Singapore Economic Development Board (EDB) showed on...

SINGAPORE biotech startups are struggling through a sharp drop in funding as investors seek greater certainty of returns.

The pandemic has put the spotlight on the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital heal...

WuXi Biologics, a contract research, development and manufacturing organisation, on Tuesday (Jul 19) announced a 10-year, S$2 billion investment plan to grow its presence in Singapore.